Table 3 Hazard ratios for recurrence and death M0 R0-1
From: Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
Time to recurrence | |||||
Unadjusted | Adjusteda | ||||
n (events) | HR (95 % CI) | p-value | HR (95 % CI) | p-value | |
Esophagus | |||||
IFITM1 | |||||
Low High | 23 (13) 16 (9) | 1.00 1.09 (0.47-2.56) | 0.836 | 1.00 3.05 (1.09-8.53) | 0.034 |
GE junction | |||||
IFITM1 | |||||
Low High | 16 (10) 17 (10) | 1.00 1.09 (0.45-2.62) | 0.852 | 1.00 1.50 (0.59-3.82) | 0.400 |
Stomach | |||||
IFITM1 | |||||
Low High | 30 (19) 20 (5) | 1.00 0.33 (0.12-0.88) | 0.026 | 1.00 0.32 (0.12-0.87) | 0.026 |
Overall survival | |||||
Unadjusted | Adjustedb | ||||
n (events) | HR (95 % CI) | p-value | HR (95 % CI) | p-value | |
Esophagus | |||||
IFITM1 | |||||
Low High | 31 (20) 18 (11) | 1.00 0.99 (0.47-2.07) | 0.976 | 1.00 2.71 (1.11-6.67) | 0.029 |
GE junction | |||||
IFITM1 | |||||
Low High | 19 (15) 19 (16) | 1.00 1.00 (0.49-2.03) | 0.995 | 1.00 0.97 (0.44-2.15) | 0.937 |
Stomach | |||||
IFITM1 | |||||
Low High | 32 (22) 24 (15) | 1.00 0.83 (0.43-1.62) | 0.592 | 1.00 0.80 (0.39-1.64) | 0.539 |